Search

Your search keyword '"Kauert, Andreas"' showing total 17 results
Start Over Author "Kauert, Andreas"
17 results on '"Kauert, Andreas"'

1. Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry

Author

Tütüncü, Serdar, Olma, Manuel, Kunze, Claudia, Dietzel, Joanna, Schurig, Johannes, Fiessler, Cornelia, Malsch, Carolin, Haas, Tobias Eberhard, Dimitrijeski, Boris, Doehner, Wolfram, Hagemann, Georg, Hamilton, Frank, Honermann, Martin, Jungehulsing, Gerhard Jan, Kauert, Andreas, Koennecke, Hans-Christian, Mackert, Bruno-Marcel, Nabavi, Darius, Nolte, Christian H., Reis, Joschua Mirko, Schmehl, Ingo, Sparenberg, Paul, Stingele, Robert, Völzke, Enrico, Waldschmidt, Carolin, Zeise-Wehry, Daniel, Heuschmann, Peter U., Endress, Matthias, and Haeusler, Karl Georg

Published
2022
Full Text
View/download PDF

2. Efficacy and safety of hyperbaric oxygen therapy monitored by fluorescein angiography in patients with retinal artery occlusion.

Author

Chiabo, Jeremy, Kauert, Andreas, Casolla, Barbara, Contenti, Julie, Nahon-Esteve, Sacha, Baillif, Stephanie, and Arnaud, Martel

Abstract

Aims To assess the efficacy and safety of a standardised hyperbaric oxygen therapy protocol (HBOT) monitored by fluorescein angiography (FA) in patients with retinal artery occlusion (RAO). Methods It is a prospective, non-comparative, monocentric study conducted between July 2016 and March 2022. All consecutive patients diagnosed with RAO within 7 days underwent visual acuity measurement, FA, macular optical coherence tomography (OCT) and OCT-angiography. They received two daily HBOT sessions (2.5 atmosphere absolute, 90 min) until revascularisation assessed by FA. Complete ophthalmic follow-up was scheduled at day 14, day 21 and at 1 month. The main outcome measure was a best-corrected visual acuity (BCVA) improvement defined as a decrease =0.3 logMAR at 1 month. Results Thirty-one patients were included and received a mean number of 33.9 (13-56) HBOT sessions. Retinal revascularisation was observed in 48.4% and 87.1% of patients at days 14 and 21, respectively. The mean BCVA on referral and at 1 month was 1.51 logMAR and 1.10 logMAR, respectively. Fifteen (48.4%) patients achieved the main outcome measure. Six (19.4%) patients experienced minor barotrauma that did not require HBOT discontinuation. The univariate analysis showed that antiplatelet-treated patients (p=0.044) and patients with a poor initial BCVA (p=0.008) were more likely to achieve a BCVA improvement. OCT-angiography was not sensitive enough to diagnose RAO or assess revascularisation. Conclusion In RAO patients monitored by FA until spontaneous revascularisation of the central retinal artery, HBOT was effective and safe. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

3. Timing of oral anticoagulation in atrial fibrillation patients after acute ischaemic stroke and outcome after 3 months: results of the multicentre Berlin Atrial Fibrillation Registry.

Author

Olma, Manuel C., Tütüncü, Serdar, Hansen, Katrin, Grittner, Ulrike, Kunze, Claudia, Dietzel, Joanna, Schurig, Johannes, Dimitrijeski, Boris, Hagemann, Georg, Hamilton, Frank, Honermann, Martin, Jungehuelsing, Gerhard Jan, Kauert, Andreas, Koennecke, Hans-Christian, Mackert, Bruno-Marcel, Nabavi, Darius G., Schmehl, Ingo, Sparenberg, Paul, Stingele, Robert, and Voelzke, Enrico

Published
2024
Full Text
View/download PDF

4. Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry

Author

Tütüncü, Serdar, Olma, Manuel, Kunze, Claudia, Dietzel, Joanna, Schurig, Johannes, Fiessler, Cornelia, Malsch, Carolin, Haas, Tobias Eberhard, Dimitrijeski, Boris, Doehner, Wolfram, Hagemann, Georg, Hamilton, Frank, Honermann, Martin, Jungehulsing, Gerhard Jan, Kauert, Andreas, Koennecke, Hans-Christian, Mackert, Bruno-Marcel, Nabavi, Darius, Nolte, Christian H., Reis, Joschua Mirko, Schmehl, Ingo, Sparenberg, Paul, Stingele, Robert, Völzke, Enrico, Waldschmidt, Carolin, Zeise-Wehry, Daniel, Heuschmann, Peter U., Endres, Matthias, and Haeusler, Karl Georg

Published
2022
Full Text
View/download PDF

6. Correction to: Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry

Author

Tütüncü, Serdar, primary, Olma, Manuel, additional, Kunze, Claudia, additional, Dietzel, Joanna, additional, Schurig, Johannes, additional, Fiessler, Cornelia, additional, Malsch, Carolin, additional, Haas, Tobias Eberhard, additional, Dimitrijeski, Boris, additional, Doehner, Wolfram, additional, Hagemann, Georg, additional, Hamilton, Frank, additional, Honermann, Martin, additional, Jungehulsing, Gerhard Jan, additional, Kauert, Andreas, additional, Koennecke, Hans-Christian, additional, Mackert, Bruno-Marcel, additional, Nabavi, Darius, additional, Nolte, Christian H., additional, Reis, Joschua Mirko, additional, Schmehl, Ingo, additional, Sparenberg, Paul, additional, Stingele, Robert, additional, Völzke, Enrico, additional, Waldschmidt, Carolin, additional, Zeise-Wehry, Daniel, additional, Heuschmann, Peter U., additional, Endres, Matthias, additional, and Haeusler, Karl Georg, additional

Published
2021
Full Text
View/download PDF

7. Off-label-dosing of non-vitamin K-dependent oral antagonists in AF patients before and after stroke: results of the prospective multicenter Berlin Atrial Fibrillation Registry

Author

Tütüncü, Serdar, primary, Olma, Manuel, additional, Kunze, Claudia, additional, Dietzel, Joanna, additional, Schurig, Johannes, additional, Fiessler, Cornelia, additional, Malsch, Carolin, additional, Haas, Tobias Eberhard, additional, Dimitrijeski, Boris, additional, Doehner, Wolfram, additional, Hagemann, Georg, additional, Hamilton, Frank, additional, Honermann, Martin, additional, Jungehulsing, Gerhard Jan, additional, Kauert, Andreas, additional, Koennecke, Hans-Christian, additional, Mackert, Bruno-Marcel, additional, Nabavi, Darius, additional, Nolte, Christian H., additional, Reis, Joschua Mirko, additional, Schmehl, Ingo, additional, Sparenberg, Paul, additional, Stingele, Robert, additional, Völzke, Enrico, additional, Waldschmidt, Carolin, additional, Zeise-Wehry, Daniel, additional, Heuschmann, Peter U., additional, Endress, Matthias, additional, and Haeusler, Karl Georg, additional

Published
2021
Full Text
View/download PDF

11. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany—Updated series of 120 cases

Author

Kermer, Pawel, primary, Eschenfelder, Christoph C, additional, Diener, Hans-Christoph, additional, Grond, Martin, additional, Abdalla, Yasser, additional, Abraham, Alexej, additional, Althaus, Katharina, additional, Becks, Gebhard, additional, Berrouschot, Jörg, additional, Berthel, Jörg, additional, Bode, Felix J., additional, Burghaus, Lothar, additional, Cangür, Hakan, additional, Daffertshofer, Michael, additional, Edelbusch, Sebastian, additional, Eggers, Jürgen, additional, Gerlach, Rüdiger, additional, Gröschel, Klaus, additional, Große-Dresselhaus, Florian, additional, Günther, Albrecht, additional, Haase, Claus G, additional, Haensch, Carl-Albrecht, additional, Harloff, Andreas, additional, Heckmann, Joseph G, additional, Held, Valentin, additional, Hieber, Maren, additional, Kauert, Andreas, additional, Kern, Rolf, additional, Kerz, Thomas, additional, Köhrmann, Martin, additional, Kraft, Peter, additional, Kühnlein, Peter, additional, Latta, Jan, additional, Leinisch, Elke, additional, Lenz, Arne, additional, Leithner, Christoph, additional, Neumann-Haefelin, Tobias, additional, Mäurer, Mathias, additional, Müllges, Wolfgang, additional, Nolte, Christian H, additional, Obermann, Mark, additional, Partowi, Someieh, additional, Patzschke, Peer, additional, Poli, Sven, additional, Pulkowski, Ulrich, additional, Purrucker, Jan, additional, Rehfeldt, Torsten, additional, Ringleb, Peter A, additional, Röther, Joachim, additional, Rossi, Raluca, additional, El-Sabassy, Hazem, additional, Sauer, Oliver, additional, Schackert, Gabriele, additional, Schäfer, Niklas, additional, Schellinger, Peter D, additional, Schneider, Andreas, additional, Schuppner, Ramona, additional, Schwab, Stefan, additional, Schwarte, Olav, additional, Seitz, Rüdiger J, additional, Senger, Sebastian, additional, Shah, Yogesh P, additional, Sindern, Eckhart, additional, Sparenberg, Paul, additional, Steiner, Thorsten, additional, Szabo, Kristina, additional, Urbanek, Christian, additional, Sarnowksi, Bettina von, additional, Weissenborn, Karin, additional, Wienecke, Peter, additional, Witt, Karsten, additional, Wruck, Robert, additional, and Wunderlich, Silke, additional

Published
2020
Full Text
View/download PDF

12. Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry

Author

Haeusler, Karl Georg, primary, Tütüncü, Serdar, additional, Kunze, Claudia, additional, Schurig, Johannes, additional, Malsch, Carolin, additional, Harder, Janek, additional, Wiedmann, Silke, additional, Dimitrijeski, Boris, additional, Ebinger, Martin, additional, Hagemann, Georg, additional, Hamilton, Frank, additional, Honermann, Martin, additional, Jungehulsing, Gerhard Jan, additional, Kauert, Andreas, additional, Koennecke, Hans-Christian, additional, Leithner, Christoph, additional, Mackert, Bruno-Marcel, additional, Masuhr, Florian, additional, Nabavi, Darius, additional, Rocco, Andrea, additional, Schmehl, Ingo, additional, Schmitz, Bettina, additional, Sparenberg, Paul, additional, Stingele, Robert, additional, von Brevern, Michael, additional, Völzke, Enrico, additional, Dietzel, Joanna, additional, Heuschmann, Peter U, additional, and Endres, Matthias, additional

Published
2019
Full Text
View/download PDF

13. Antagonizing dabigatran by idarucizumab in cases of ischemic stroke or intracranial hemorrhage in Germany – A national case collection

Author

Kermer, Pawel, primary, Eschenfelder, Christoph C, additional, Diener, Hans-Christoph, additional, Grond, Martin, additional, Abdalla, Yasser, additional, Althaus, Katharina, additional, Berrouschot, Jörg, additional, Cangür, Hakan, additional, Daffertshofer, Michael, additional, Edelbusch, Sebastian, additional, Gröschel, Klaus, additional, Haase, Claus G, additional, Harloff, Andreas, additional, Held, Valentin, additional, Kauert, Andreas, additional, Kraft, Peter, additional, Lenz, Arne, additional, Müllges, Wolfgang, additional, Obermann, Mark, additional, Partowi, Someieh, additional, Purrucker, Jan, additional, Ringleb, Peter A, additional, Röther, Joachim, additional, Rossi, Raluca, additional, Schäfer, Niklas, additional, Schneider, Andreas, additional, Schuppner, Ramona, additional, Seitz, Rüdiger J, additional, Szabo, Kristina, additional, and Wruck, Robert, additional

Published
2017
Full Text
View/download PDF

16. Oral anticoagulation in patients with atrial fibrillation and acute ischaemic stroke: design and baseline data of the prospective multicentre Berlin Atrial Fibrillation Registry.

Author

Haeusler KG, Tütüncü S, Kunze C, Schurig J, Malsch C, Harder J, Wiedmann S, Dimitrijeski B, Ebinger M, Hagemann G, Hamilton F, Honermann M, Jungehulsing GJ, Kauert A, Koennecke HC, Leithner C, Mackert BM, Masuhr F, Nabavi D, Rocco A, Schmehl I, Schmitz B, Sparenberg P, Stingele R, von Brevern M, Völzke E, Dietzel J, Heuschmann PU, and Endres M

Subjects
Acute Disease, Administration, Oral, Adolescent, Adult, Aged, Aged, 80 and over, Atrial Fibrillation complications, Berlin epidemiology, Brain Ischemia epidemiology, Brain Ischemia etiology, Female, Follow-Up Studies, Humans, Incidence, Male, Middle Aged, Prognosis, Prospective Studies, Young Adult, Anticoagulants administration & dosage, Atrial Fibrillation drug therapy, Brain Ischemia prevention & control, Registries
Abstract

Aims: The Berlin Atrial Fibrillation Registry was designed to analyse oral anticoagulation (OAC) prescription in patients with atrial fibrillation (AF) and acute ischaemic stroke., Methods and Results: This investigator-initiated prospective multicentre registry enrolled patients at all 16 stroke units located in Berlin, Germany. The ongoing telephone follow-up is conducted centrally and will cover 5 years per patient. Within 2014 and 2016, 1080 patients gave written informed consent and 1048 patients were available for analysis. Median age was 77 years [interquartile range (IQR) 72-83], 503 (48%) patients were female, and 254 (24%) had a transient ischaemic attack (TIA). Overall, 470 (62%) out of 757 patients with known AF and a (pre-stroke) CHA2DS2-VASc ≥ 1 were anticoagulated at the time of stroke. At hospital discharge, 847 (81.3%) of 1042 patients were anticoagulated. Thereof 710 (68.1%) received a non-vitamin K-dependent oral anticoagulant (NOAC) and 137 (13.1%) a vitamin K antagonist (VKA). Pre-stroke intake of a NOAC [odds ratio (OR) 15.6 (95% confidence interval, 95% CI 1.97-122)] or VKA [OR 0.04 (95% CI 0.02-0.09)], an index TIA [OR 0.56 (95% CI 0.34-0.94)] rather than stroke, heart failure [OR 0.49 (95% CI 0.26-0.93)], and endovascular thrombectomy at hospital admission [OR 12.9 (95% CI 1.59-104)] were associated with NOAC prescription at discharge. Patients' age or AF type had no impact on OAC or NOAC use, respectively., Conclusion: About 60% of all registry patients with known AF received OAC at the time of stroke or TIA. At hospital discharge, more than 80% of AF patients were anticoagulated and about 80% of those were prescribed a NOAC., (Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.)

Published
2019
Full Text
View/download PDF

17. Dynamic spin labeling angiography in extracranial carotid artery stenosis.

Author

Warmuth C, Rüping M, Förschler A, Koennecke HC, Valdueza JM, Kauert A, Schreiber SJ, Siekmann R, and Zimmer C

Subjects
Aged, Aged, 80 and over, Humans, Male, Middle Aged, Angiography methods, Carotid Artery, External, Carotid Stenosis diagnostic imaging
Abstract

Background and Purpose: Similar to digital subtraction angiography, dynamic spin labeling angiography (DSLA) provides time-resolved measurements of the influx of blood into the cerebral vascular tree. We determined whether DSLA may help in assessing the degree of stenosis and whether it provides information about intracerebral collateralization and allows us to monitor the hemodynamic effects of vascular interventions., Methods: We developed a segmented DSLA sequence that allowed the formation of images representing inflow delays in 41-ms increments. Thirty patients with unilateral carotid artery stenosis and 10 control subjects underwent DSLA. Arrival times of the labeled arterial blood bolus were measured in the carotid siphon (CS) and the middle cerebral artery (MCA) on both sides, and the corresponding side-to-side arrival time differences (ATDs) were calculated. ATDs before and after carotid endarterectomy or percutaneous angioplasty were studied in 10 patients., Results: The degree of stenosis was significantly correlated with ATD in the cerebral vessels. Receiver operating characteristic analysis yielded a cutoff CS ATD of 110 ms to separate stenoses <70% from those > or =70%, with a sensitivity of 90% and a specificity of 67%. In one third of patients, ATD was higher in the MCA than in the CS; this finding suggested an absence of collateralization. Most patients had reduced ATD in the MCA. The degree of ATD reduction was regarded as a quantitative measure of collateralization. Successful intervention resulted in normalized ATDs., Conclusion: DSLA is a promising method that allowed us to noninvasively quantify the hemodynamic effect of extracranial carotid stenosis and the resulting intracranial collateralization.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results